Skip to content

RNTX RNTX Earnings yield

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Gilead Sciences logo
Gilead SciencesGILD
5.3%+1.1pp
AbbVie logo
AbbVieABBV
0.9%-0.2pp
CTO
Citius Oncology, Inc.CTOR
-77.7%+7,484pp
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-10%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
1%+0.5pp

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Calculated from RNTX’s reported figures.

Based on trailing twelve months.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's earnings yield?
RNTX (RNTX) reported earnings yield of -137.7% in Q1 2026.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.